Davis Capital Management
BIIB icon

Davis Capital Management’s Biogen BIIB Stock Holding History

Davis Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.9K Buy
44
+40
+1,000% +$8.48K 0.01% 253
2026
Q2 		$864 Buy
4
+2
+100% +$383 ﹤0.01% 512
2026
Q1 		$367 Hold
2
– – ﹤0.01% 463
2025
Q4 		$352 Hold
2
– – ﹤0.01% 469
2025
Q3 		$280 Buy
+2
New +$270 ﹤0.01% 502

Other funds holding BIIB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Davis Capital Management's BIIB Position: Q3 2026 in Review

Davis Capital Management increased its Biogen (BIIB) stake by 1,000% in Q3 2026, buying an estimated $8.48K and bringing the position to 44 shares worth $9.9K. The position accounts for 0.01% of the portfolio, ranked #253.

Davis Capital Management first reported a position in BIIB in Q3 2025 and has held it in 5 quarters since. 532 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Davis Capital Management held 44 shares of Biogen worth $9.9K as of Q3 2026.
  • Davis Capital Management bought 40 Biogen shares in Q3 2026, an estimated $8.48K.
  • Biogen made up 0.01% of Davis Capital Management's portfolio in Q3 2026, its #253 holding.
  • Davis Capital Management first reported a position in Biogen in Q3 2025 and has held it in 5 quarters since.
  • 532 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.